Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection--What Do We Know, and What More Do We Need to Know?
- PMID: 26416944
- PMCID: PMC4594072
- DOI: 10.2215/CJN.08060715
Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection--What Do We Know, and What More Do We Need to Know?
Keywords: cardiovascular disease; chronic kidney disease; hemodialysis.
Comment on
-
Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection.Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1799-805. doi: 10.2215/CJN.01090115. Epub 2015 Sep 28. Clin J Am Soc Nephrol. 2015. PMID: 26416943 Free PMC article.
References
-
- Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, Chen JT, Cope E, Gipson D, He K, Herman W, Heung M, Hirth RA, Jacobsen SS, Kalantar-Zadeh K, Kovesdy CP, Leichtman AB, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, O’Hare AM, Pisoni R, Plattner B, Port FK, Rao P, Rhee CM, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, Eggers PW, Agodoa LY, Abbott KC: US Renal Data System 2014 annual data report: Epidemiology of kidney disease in the United States. Am J Kidney Dis 65[Suppl 1]: A7, 2015 - PMC - PubMed
-
- Drüeke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ, Gausson V, London GM: Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106: 2212–2217, 2002 - PubMed
-
- Himmelfarb J, Tuttle KR: New therapies for diabetic kidney disease. N Engl J Med 369: 2549–2550, 2013 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
